Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1109448 NASHVILLE, TN
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,564,458
+$3,713,962 QoQ
Shares Held
27,095
+11.5% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. LGND ranks #57 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,564,458 27,095
2026-03-31 $4,850,496 24,295
2025-12-31 $4,570,010 24,171
2025-09-30 $3,941,896 22,253
2025-06-30 $2,350,561 20,677
2025-03-31 $2,173,979 20,677
2024-12-31 $2,212,218 20,646
2024-09-30 $2,212,589 22,106
2024-06-30 $1,862,651 22,106
2024-03-31 $1,682,688 23,019
2023-12-31 $1,539,743 21,559
2023-09-30 $1,293,013 21,579
2023-06-30 $1,555,845 21,579
2023-03-31 $1,757,348 23,890
2022-12-31 $1,691,643 25,324
2022-09-30 $2,179,270 25,308
2022-06-30 $2,266,810 25,407
2022-03-31 $2,853,084 25,363
2021-12-31 $3,898,414 25,239
2021-09-30 $3,836,035 27,534
2021-06-30 $5,497,123 41,902
2021-03-31 $6,839,209 44,862
2020-12-31 $4,380,273 44,045
2020-09-30 $5,777,153 60,608
2020-06-30 $7,519,785 67,231
2020-03-31 $4,955,209 68,141